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Abstract
Background
Coverage of malaria in pregnancy interventions in sub-Saharan Africa is suboptimal. We
undertook a systematic examination of the operational, socio-economic and cultural con-
straints to pregnant women’s access to intermittent preventive treatment (IPTp), long-last-
ing insecticide-treated nets (LLINs) and case management in Kenya and Mali to provide
empirical evidence for strategies to improve coverage.
Methods
Focus group discussions (FGDs) were held as part of a programme of research to explore
the delivery, access and use of interventions to control malaria in pregnancy. FGDs were
held with four sub-groups: non-pregnant women of child bearing age (aged 15–49 years),
pregnant women or mothers of children aged<1 year, adolescent women, and men. Con-
tent analysis was used to develop themes and sub-themes from the data.
Results
Women and men’s perceptions of the benefits of antenatal care were generally positive;
motivation among women consisted of maintaining a healthy pregnancy, disease preven-
tion in mother and foetus, checking the position of the baby in preparation for delivery, and
ensuring admission to a facility in case of complications. Barriers to accessing care related
to the quality of the health provider-client interaction, perceived health provider skills and
malpractice, drug availability, and cost of services. Pregnant women perceived themselves
and their babies at particular risk from malaria, and valued diagnosis and treatment from a
health professional, but cost of treatment at health facilities drove women to use herbal
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remedies or drugs bought from shops. Women lacked information on the safety, efficacy
and side effects of antimalarial use in pregnancy.
Conclusion
Women in these settings appreciated the benefits of antenatal care and yet health services
in both countries are losing women to follow-up due to factors that can be improved with
greater political will. Antenatal services need to be patient-centred, free-of-charge or highly
affordable and accountable to the women they serve.
Introduction
Pregnant women living in malaria endemic areas of sub-Saharan Africa are at substantial risk
of the adverse consequences of malaria in pregnancy [1], and each year an estimated 55 million
pregnancies occur in areas with stable P. falciparummalaria [2]. These adverse consequences
can be prevented through the use of two highly effective prevention interventions, intermittent
preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) [3] and long-lasting insec-
ticide-treated nets (LLINs) [4]. In areas of stable malaria transmission in Africa WHO recom-
mends a package of intermittent preventive treatment (IPTp) with sulphadoxine–
pyrimethamine (SP) and use of insecticide-treated nets (ITNs), together with effective case
management of clinical malaria and anaemia [5,6]. Until 2006, WHO recommended two doses
of SP for IPTp, taken one month apart commencing after quickening (approximately 18 weeks
gestation) [7,8], and together with ITNs, is routinely delivered through antenatal clinics. WHO
Antenatal care guidelines recommend four ANC visits during every pregnancy, starting as
early in pregnancy as possible, with the first visit in the first trimester, one in the second trimes-
ter and two visits in the third trimester [9]. Despite relatively high coverage of antenatal clinic
(ANC) attendance among pregnant women in sub-Saharan Africa, coverage of both interven-
tions across many countries in the region is low [10], limiting achievement of their full poten-
tial effectiveness or impact on maternal and neonatal outcomes [11,12]. Case management
practices for malaria illness during pregnancy are less well understood and exclusion from na-
tional population and facility-based surveys suggests the need for more systematic evaluation
through research.
Kenya in East Africa and Mali in West Africa represent two countries with different malaria
epidemiology, health systems and socio-economic and cultural settings, both with low coverage
of malaria in pregnancy interventions. Kenya adopted the IPTp policy in 1999 and the ITN
policy in 2001, and Mali in 2003 and 2006, respectively. According to national survey data for
Kenya and Mali available in 2009 when this study was designed, the proportion of women re-
ceiving2 doses of IPTp-SP was 4% in both Kenya and Mali, and ITN use the night before the
survey was 4% and 49%, respectively [13,14]. Coverage of2 doses of IPTp was substantially
lower than the proportion of women making 2 or more ANC visits (84% and 63% in Kenya
and Mali respectively) [13,14], indicating substantial missed opportunities to provide IPTp
when the pregnant woman was at the ANC. We undertook a systematic examination of the op-
erational, socio-economic and cultural constraints to pregnant women’s access and use of
IPTp, LLINs and case management in the diverse settings of these two countries to provide
data from which rational strategies aimed at improving coverage could be developed and
implemented. We used a combination of health facility and community assessments using
quantitative and qualitative methodologies. The household survey, health facility surveys and
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in-depth interviews with health staff are described elsewhere [15–18]. Here we report the find-
ings of a qualitative study focussing on the community level in Kenya and Mali.
Methods
Ethics statement
The study was approved by the ethical committees of the Kenya Medical Research Institute’s
(KEMRI) National Ethics Review Committee, Kenya; the Institutional Ethical Committee of
the Faculty of Medicine, Pharmacy and Odonto-stomatology, University of Bamako in Mali;
the Liverpool School of Tropical Medicine, UK; and the London School of Hygiene and Tropi-
cal Medicine, UK; and for the Kenya study, ethics approval was also obtained from the Centres
for Disease Control and Prevention, Atlanta, Georgia, USA. All ethics committees approved
verbal informed consent to be obtained from study participants as the study procedures posed
minimal risk to participants and to avoid the potentially negative influence of written consent
on rapport between participants and researchers. With participants’ prior agreement, verbal
consent was obtained and recorded prior to the focus group discussions. Pregnant women aged
15–17 years are considered emancipated minors in Kenya and Mali and were consented direct-
ly; for adolescents who did not fall into this category, verbal assent of the participant and con-
sent from the guardian was witnessed and recorded. During transcription, any names were
replaced with codes to ensure anonymity and digital recordings were deleted once transcription
and translation were completed and quality approved.
Study sites and context
The study was conducted in Kenya and Mali, in 2009 and 2010 respectively, chosen to repre-
sent very different African health system, epidemiological, cultural and socioeconomic contexts
as part of a larger study to evaluate the barriers to the scale up and use of interventions to con-
trol malaria in pregnancy [15–18].
Kenya. This work was conducted under KEMRI and CDC’s collaboration in western
Kenya. The Kenya study site was Greater Nyando District, Nyanza Province, now divided into
three sub-Counties, Nyando, Muhoroni and Nyakach, each managed by a district commission-
er. The district has a population of 355,800 projected from the 1999 census, with more than
90% of this population living in rural areas. The district has a total of 40 health facilities of
which 24 are government-owned, five by missions, seven privately owned and four communi-
ty-operated. The most common ethnic group is Luo, who live on the shores of Lake Victoria
and the main economic occupation is subsistence agriculture and cultivating cash crops such
as rice, sugar cane, sisal and fishing. Malaria in Nyando District is perennial holo-endemic
with a parasite prevalence of 8.3% among women of child bearing age (2008 unpublished data,
KEMRI/CDC). HIV prevalence among women aged 15–49 years is higher in Nyanza Province
compared to all other provinces, 18% compared to a national average of 9% [19].
In line with WHO recommendations on focussed antenatal care (FANC), the Kenya Na-
tional Guidelines for the diagnosis, treatment and prevention of malaria at the time the study
was conducted stated that a package of interventions should be delivered through antenatal
care which, in areas of high transmission, includes malaria in pregnancy and prevention of
mother to child transmission (PMTCT) alongside other components [20]. These include a free
LLIN for all women at first ANC visit and two doses of IPTp-SP given at each ANC visit after
quickening, administered under directly observed therapy (DOT), unless SP has been taken in
the prior 4 weeks or the woman is HIV-infected and taking daily cotrimoxazole prophylaxis
for opportunistic infections. Malaria episodes should be treated with a 7-day course of oral
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quinine (all trimesters) or artemether-lumefantrine (AL) (2nd & 3rd trimester and 1st trimester
if quinine is not available) [21].
Mali. The Mali study site was Segou District, Segou Region, which has a total population
of 448,552 projected from the 1998 census, with more than 60% of this population living in
rural areas. The most common ethnic groups are Bamanan and Sarakole/Soninke, and the
main economic occupation is subsistence agriculture. The district has a total of 26 functioning
health structures comprising one hospital and one district level health facility (Centre de santé
de reference [CSRef]), both of which are government operated and 24 community-owned
health centres of which eight are headed by a physician paid by the government and 16 headed
by a nurse paid by the community. Malaria in Segou Region is seasonal ranging from holo-en-
demic in the southern part of the district to meso-endemic in the north. HIV prevalence
among women aged 15–49 years is higher in Segou Region compared to the national average,
1.7% vs 1.4% [14].
The health system in Mali has been described elsewhere [17]. The government funds health
facilities to district level only, including one hospital and one CSRef. All health facilities below
this level are funded by communities themselves, in some cases with assistance from non-gov-
ernmental organisations. At the time of the study, malaria in pregnancy services provided
through ANC included two doses of IPTp administered by DOT between month 4 and 8 (in-
clusive) gestation, with each dose given at least one month apart, and three doses for women
who are HIV positive, in addition to a free LLIN to all women at first ANC visit [22].
Data collection and participants
The study was undertaken during the rainy season, February-March at the start of the long
rainy season in Kenya, and September towards the end of the rainy season in Mali, to capture
experience and use of malaria in pregnancy interventions as a current or fairly recent event.
Focus group discussions (FGDs) were held in a sample of women of child bearing age (aged
15–49 years) living in two villages from within the study areas. There were three sub-groups
within this population, to represent both pregnant and non pregnant women, and adolescents
as a high risk group: women who were not pregnant, women who were either currently preg-
nant or a mother of a child under 1 year, and adolescent girls. FGDs were also held with men
living in the selected villages aged 18 years or older. Each sub-group contained 8–12 partici-
pants and two FGDs were held per sub-group. Sessions ran for approximately one hour, were
conducted in the local languages, Dholuo (Kenya) and Bambara (Mali), and were digitally
recorded.
In Kenya, the FGDs took place in Ochoria and Kamahawa villages in Koru and Kakola loca-
tions respectively, selected randomly using a sampling frame. The FGDs were conducted by an
experienced female social scientist (FA) assisted by a community health worker (note taker).
FGD participants were randomly selected from a list of village members provided by the village
chief, and field staff visited consecutive names on the list until 12 community members had
agreed to participate. In Mali, FGDs were undertaken in Banankoro and Sagni villages, repre-
senting urban and rural communities respectively, and participants selected with the help of
the village chief and head of the CSCOMs. The FGDs with women were undertaken by three
female researchers and an experienced male social scientist (SD) for men. Participants were re-
cruited with the help of community leaders including village chiefs, assistant chiefs and village
elders, and the location of the focus groups chosen by the community based on their conve-
nience and proximity to all participants.
FGD guides were developed covering the same topics for both countries. Exploration of the
women’s opinions focussed on: experiences during ANC visits including perceptions of
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services provided at ANC, perceptions of malaria risk and patterns of care seeking, experiences
with ITNs, IPTp-SP, and antimalarial drugs for treatment of malaria, and community influ-
ences of health seeking behaviour. Exploration of the men’s opinions focussed on their views
on the same topics.
Data analysis
Transcripts were first translated from the local language into English and verified by two of the
authors (Kenya: FA; Mali: KK). The translated transcripts were read to get an overview of the
themes arising then entered into NVivo10 for data management and analysis. Data from each
site were coded separately using a combination of pre-defined themes based on the original re-
search questions and themes that emerged from the data using content analysis. Pre-defined
and emerging themes from Kenya and Mali were then compared to explore similarities and dif-
ferences in the experiences and beliefs concerning access and use of ANC and of malaria in
pregnancy interventions, and the views of men in relation to those of women. The FGD find-
ings are used to complement findings from household surveys, and are discussed in relation to
data collected from health facilities, in order to strengthen, compare and contrast findings
from women and health providers, and from women enrolled in community and health facility
settings in each country.
The policy and programme implications of the findings were explored using the WHO
health system framework comprising six building blocks: Governance, Human resources,
Products and technologies, Service delivery, Information systems and Financing [23].
Results
A total of 158 participants were recruited into the FGDs, 79 in Kenya and 79 in Mali. The par-
ticipant numbers by group, village, country and demographics are provided in Table 1. Pre-de-
fined and emergent themes were coded around the five key topics in the topic guide, which
were pregnant women’s: access and use of ANC; access and use of case management of malaria
in pregnancy; access and use of IPTp; access and use of ITNs; and sources of information, in-
cluding social and cultural influences.
Access and use of ANC
Factors affecting pregnant women’s access and use of ANC emerging from the data were coded
into five main themes: perceptions of the benefits of ANC; experiences at ANC (both positive
and negative); health staff corruption and malpractice; poor attitudes of health staff; long wait-
ing times; shame or fear of pregnancy disclosure; and distance and/or cost (Table 2).
Perceptions of benefits of ANC. The key motivation for women to attend ANC in both
Kenya and Mali was to have their pregnancy monitored and managed in the hope this would
lead to a healthy pregnancy and, ultimately, reduce the risk of complications at delivery. Know-
ing the position of the baby was important and having the baby in the correct position for de-
livery was seen to be critical for avoiding problems at delivery. Women who didn’t attend ANC
at least once were said to risk being sent away by midwives if they came with complications at
delivery. During the FGD at Kakola village in Kenya, a 66 year old married man described the
benefit of his wife attending clinic was that she would have a record of her treatment and care,
which would be useful in case there were problems at delivery. Men in Mali were also aware of
the dangers of women not obtaining regular antenatal care, and referred to the ‘past’ when
many women died during delivery due to the absence of adequate antenatal care services.
Another key element of attending antenatal clinics referred to by women was to have tests
for HIV and other diseases, including malaria, so that ‘tablets against malaria’ could be taken
Access to Prevention and Treatment of Malaria in Pregnancy
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to safeguard the health status of both her and the unborn child. Preventing the onset of malaria
was said to save money compared to treatment of the illness once it had progressed. Knowing
one’s HIV status was more commonly mentioned by women in Kenya, where men were said to
sometimes accompany their wives as the clinics encouraged partner testing for HIV. Receiving
counselling on disease prevention and professional advice on the use of safe regimens during
pregnancy and tetanus immunisation were additional reasons cited for attending ANC. Moni-
toring and information to control high blood pressure and receiving iron was mentioned by
women in Mali but not in Kenya. Testing for blood group was mentioned in Kenya but not in
Mali.
Experiences of ANC service quality (positive and negative). Experiences of ANC were
predominantly negative, as remarked by a 28 year old, multiparous woman in Banankoro vil-
lage in Mali ‘Nobody goes to health centre for pleasure’, although there were some positive expe-
riences too. There were instances where women didn’t get all the services they would have
liked, as observed by a single, multiparous woman aged 20 in Kakola village, Kenya, who com-
plained that although they are supposed to be given a blood group test, sometimes they were
only given an HIV test. Some adolescent women were fearful of going to clinics because they
Table 1. Focus group discussion participant demographics.
FGD
group
Village Group N Average
Age
Average
Gravidity
(range)
Marital status Education
Kenya Single Married Widowed/
divorced
None Primary Secondary or
above
1 Kakola WOCBA, not
pregnant
10 28 4 (0–12) 0 10 0 1 7 2
1 Koru WOCBA, not
pregnant
10 31 5 (0–9) 1 8 1 W 0 10 0
2 Kakola Pregnant woman or
mother of child <1yr
10 26 3 (1–5) 1 9 0 1 5 4
2 Koru Pregnant woman or
mother of child <1yr
9 23 3 (1–7) 0 9 0 0 6 3
3 Kakola Adolescent 15–18yr 10 17 1 (0–1) 10 0 0 0 5 5
3 Koru Adolescent 15–18yr 10 18 2 (1–4) 0 10 0 0 8 2
4 Kakola Man 10 40 N/A 0 9 1 W 1 8 1
4 Koru Man 10 38 N/A 0 9 1 D 0 5 5†
Mali
1 Banankoro WOCBA, not
pregnant
8 45 5 (1–13) NR NR NR NR NR NR
1 Sagni WOCBA, not
pregnant
12 35 5 (0–9) NR NR NR NR NR NR
2 Banankoro Pregnant woman or
mother of child <1yr
10 28 2 (1–6) NR NR NR NR NR NR
2 Sagni Pregnant woman or
mother of child <1yr
12 28 4 (1–7) NR NR NR NR NR NR
3 Banankoro Adolescent 15–18y 8 17 0 NR NR NR NR NR NR
3 Sagni Adolescent 15–18y 9 17 NR NR NR NR NR NR NR
4 Banankoro Man 8 49 N/A NR NR NR NR NR NR
4 Sagni Man 12 40 N/A NR NR NR NR NR NR
Key: WOCBA, women of childbearing age; y, year; NR, not reported
† 2 men had been to college (R3 and R4)
doi:10.1371/journal.pone.0119848.t001
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Table 2. Factors affecting pregnant women’s access and use of ANC.
Themes KENYA: Sub-themes & Quotations from study
participants
MALI: Sub-themes & Quotations from study participants
Perceptions of beneﬁts
of ANC
To monitor pregnancy and reduce complications at
delivery
To monitor pregnancy and reduce complications at
delivery
We always go to the clinic so that when my delivery comes
in a bad way, I cannot be sent away. (R1: married woman
aged 42 years, multiparous, Kakola)
It is good for the child. During the ANC, you will know that
your child has not a good position and won’t know if you do
not go to ANC. (P7: woman aged 32 years, multiparous,
Sagni)
Sometimes the baby is lying wrongly so he/she must be
checked and also our weight is being measured. (R4,
married woman aged 30 years, multiparous, Kakola)
Last time with our grandparents, there were many deaths of
women at delivery due to the absence of ANC. Now if the
wife does not see her menses for one month and inform her
husband, her husband sends her to the health centre to
know if she is pregnant or if she has another disease. If she
is pregnant, you send her to ANC and you as the husband
remind and force her to respect the appointment days. Men
should always be involved in the health status of his family.
(P8: man aged 55 years, Sagni)
I see it good when my wife goes to the clinic because she
will have a record that can be used for the case of problem
in delivery. (R6: married man aged 66 years, Kakola).
To test for HIV or other diseases To test for HIV or other diseases
We go to clinic to be taught and be tested of malaria ad HIV
when we are pregnant. And if found with HIV we are given
medicine that can prevent the unborn from getting the
disease and also some medicine for malaria you are also
given and & vitamins. (R7: single, adolescent aged 17 years,
1 previous pregnancy, Kakola)
If you stay at home, you will not be informed on certain
diseases like ﬁbroma, diabetes, high blood pressure, HIV,
and many other diseases. (P3: woman aged 26 years,
multiparous, Banankoro)
We [men] go with them [our wives] because when the
woman goes they ask ‘where is your husband?’ mostly when
they want to test the HIV status. (R7: married man aged 23
years, Kakola)
Other reasons for attending ANC Other reasons for attending ANC
To be given some teachings how they can help the unborn
from contacting malaria and how they can prevent other
diseases not to affect the unborn. (R9: single, adolescent
aged 18 years, 1 previous pregnancy, Kakola)
During ANC, injections against tetanus are done. All this is
the advantage of ANC. (P2 : adolescent aged 17, no
previous pregnancies, Banankoro)
We always go to get the advice from the doctors and also to
get all the vaccinations [tetanus toxoid]. (R2, married woman
aged 35 years, multiparous, Koru)
They tell you how to take your drug, when to come for your
appointment. The advantages of ANC are enormous, the
doctors give counselling on the regimens to adopt, check
your blood pressure. (P4: woman aged 30 years,
multiparous, Banankoro)
Experiences at ANC
(both positive and
negative)
When you go to the clinic, your blood should be tested to
determine like HIV status and blood group things like that
but sometimes you go but they just test HIV status only.
(R10: single woman aged 20, multiparous, Kakola)
What discourages me is the behaviour of new nurses. . . .
The big doctors try and give hand to the new doctors that
have no experience. Young nurses don’t know the position
of the foetus. I don’t want the fact that they want us to be
examined by the young doctors, which is why I don’t want to
go there now. (P9: woman aged 25, multiparous, Banankoro)
Sometimes a doctor can just leave a patient even dying in
the queue saying that their time for lunch or leaving for home
has reached so they may leave a patient dying and this
always annoys very much. (R10: single woman aged 20, 1
previous pregnancy, Kakola)
From the beginning to the end of the pregnancy I did not get
sick. During my ANC, they received me very well and I did
not any difﬁculty during the delivery. (P5: adolescent aged
16 years, no previous pregnancies, Banankoro)
Nobody goes to health centre because of pleasure! (P7:
woman aged 28 years, multiparous, Banankoro)
(Continued)
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Table 2. (Continued)
Themes KENYA: Sub-themes & Quotations from study
participants
MALI: Sub-themes & Quotations from study participants
Health staff corruption
and malpractice
You can go and make a line and see that you are about to
reach, but when their relative or some rich person had come,
they will take them in the front and give them treatment. . . .
they are always corrupt.(R1, single, adolescent aged 18
years, 1 previous pregnancy, Kakola)
The reception must be very attractive at the health centre.
Sometimes the doctor comes to the health centre and do
not receive people for consultation. They transfer their duties
to the nurse or midwife, while this [person] cannot do the
work. (P7: adolescent aged 16, no previous pregnancies,
Banankoro)
If you go to private hospitals you can be forced to be tested
but this should only be your wish so as to know your status.
(R8: married, adolescent aged 17 years, 3 previous
pregnancies all alive, Koru).
Poor attitudes of health
staff
Sometimes they can call your name twice and you don’t
hear, so when you go inside they will start harassing you
saying we didn’t send you! We were not there! So if you go
for the ﬁrst time and they handle you like that, then you will
not go for the second time like for me they handled me that
way but I left and even left for them the book and only waited
for six months then went to Kisumu. (R9: single, adolescent
aged 18 years, 1 previous pregnancy, Kakola)
Doctors must be kind with us. There are certain doctors who
are not very kind and shout at pregnant women and when
you go for delivery some insult you. (P8: woman aged 25
years, multiparous, Banankoro)
What discourage people is that they are neglected, the
manner the health receive patient is not good as it does not
create conﬁdence. .... That is the reason why people don’t
want to go to the health centre, the doctors are not
accessible. (P1: man aged 71, Banankoro)
Long waiting times . . . if it reaches twelve o’clock, they will go for lunch and tell
you to wait until two pm.(R1, single, adolescent aged 18
years, 1 previous pregnancy, Kakola)
Sometimes you can spend one hour or more without seeing
the doctors. That is the reason why people don’t want to go
to the health centre, the doctors are not accessible. But,
even if they are not good in receiving patient, you are
obliged to go there and to be very patient. (P1: man aged
71, Banankoro)
Shame or fear of
pregnancy disclosure
It is feeling ashamed, because sometimes you are going to
the clinic at the same time your mother is also going now
you feel ashamed. (R9: single, adolescent aged 18 years, 1
previous pregnancy, alive, Kakola)
The husband asks [you] to hide the pregnancy because
pregnancy is always a psychological problem. (P8 : woman
aged 27 years, multiparous, Sagni)
It is feeling ashamed because sometimes you have not tried
so you can ask someone, what do they normally ask, they
ask if you are married and other things so it is only feeling
ashamed. (R4, single, adolescent aged 17 years, no
previous pregnancies, Kakola)
Because during pregnancy, women get many discomfort.
For each discomfort you can’t go to the health centre
otherwise your husband will not be happy on you. They say
that always to pose ﬁnancial problems. (P10 : woman aged
28 years, 4 previous pregnancies, Sagni)
Some fear that they will be seen while pregnant. (R4: single,
adolescent aged 17 years, no previous pregnancies, Kakola)
Distance The hospitals are far and sometimes you are in the interior so
when you go, you can reach when tired and the nurses will
not treat well because you also don’t have money. (R4,
single, adolescent aged 17 years, no previous pregnancies,
Kakola)
For example if the baby is not in a good position, because
here we don’t have the means of quick transportation and it
is very frequent that people are killed because of that. (P2:
woman aged 23 years, multiparous, Sagni)
Cost People always go to the TBAs just because of poverty and
lack of money but they are not good (R6: married man aged
66 years, Kakola).
If you don’t have money and your husband also, you are
obliged to stay at home. (P6: woman aged 36 years,
multiparous, Banankoro)
I went and they asked me if I have ever done it [ANC] and I
said no it’s when I want to start and they needed money and
I didn’t have money so they started quarrelling why I didn’t
have money and it is done with money. (R10: single,
adolescent aged 17 years, 1 pregnancy, Kakola)
doi:10.1371/journal.pone.0119848.t002
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would be tested for HIV, whereas others were afraid of taking ‘medicines’ or of being pricked
for a blood test. Although health staff at ANC were generally considered to be well trained and
experienced, there were examples in Mali where mothers reported that young nurses were un-
able to do essential procedures such as determining the position of the foetus, and some
women stated that they avoided attending particular clinics for that reason.
Health staff corruption or malpractice. Corruption among staff was identified as a prob-
lem in Kenya, with staff demanding bribes before agreeing to see patients and showing favour-
itism toward ‘rich’ clients. Private sector providers in Kenya reportedly refused to see patients
unwilling to have HIV tests. In Mali, doctors were reported to sometimes refer their duties to
the nurse or midwife, who was unable to do the work of a doctor.
Poor attitudes of health staff. Women in both countries complained about the rude and
sometimes bullying behaviour of health staff, both doctors and nurses. Women in Mali claimed
they were frequently shouted at and insulted, and were often neglected. Neglect was also men-
tioned in Kenya, where a single, 20 year old woman in Kakola village with one previous preg-
nancy woman said patients were left in a queue whilst the doctor went for lunch. Another
woman in Kenya reported delaying ANC until the 6th month of pregnancy due to the rudeness
of the nurses. Women in Mali reported lack of staff morality and ‘poor reception’ at health fa-
cilities as reasons for avoiding certain health facilities.
Long waiting times. Women and men in both Kenya and Mali complained of long wait-
ing times at clinics. In Kenya, women said they were made to wait for two hours between 12–
2pm whilst the nurses ‘went for lunch’. In Mali, long waiting times were said to be a disincen-
tive for patients attending health centres.
Shame or fear of pregnancy disclosure. Shame and fear of pregnancy disclosure was a
common theme in both countries, but of very different natures. In Kenya, shame was associat-
ed with an adolescent being pregnant out of wedlock, or being pregnant at the same time as
their mother so that they had to attend the clinic together. In Mali, women were conscious of
not disclosing ailments associated with pregnancy to their husbands; husbands perceived ail-
ments to be too frequent causing them irritation due to the costs associated with seeking care,
for which the husband is responsible. A 27 year old multiparous woman in Sagni village said
she did not like to disclose her pregnancy because her husband regarded pregnancy as a ‘psy-
chological problem’.
Distance and/or Cost. Distance from a hospital or health facility was cited as a problem
mainly because of lack of transportation, especially in Mali where lack of transport was said to
result in the death of many women, for example when the baby was not in the correct position
at delivery. Lack of money was said to be the main barrier to attending ANC. In Kenya, dis-
tance and lack of money went hand in hand, and money was seen as an essential requirement
to receiving antenatal services. There were examples in both countries where women were of-
fered a credit system. In Mali, this involved a temporary credit, applied by the health facility,
whilst women found the money to reimburse the clinic. In Kenya, a district hospital was said to
sponsor patients who could not afford to pay for inpatient care.
Access and use of treatment for malaria
Factors affecting pregnant women’s treatment seeking for malaria emerging from the data
were categorised into six main themes: perceptions of illnesses and diagnosis; perceptions of
treatment drugs; experience of treatment drugs; pregnancy disclosure; cost (affecting source
and type of treatment); and perceptions of different providers and other factors affecting source
of treatment (Table 3).
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Perceptions of illnesses and diagnosis. Malaria in pregnancy was widely considered to be
dangerous and a serious threat to both the pregnant women and their unborn children, causing
‘weakening the blood’, headache, vomiting, hot body and dizziness. It was said to result in
small babies, babies born with malaria, abortion, and death. Malaria was described as a hidden
illness that can kill fast, and could easily be confused with pregnancy symptoms (Mali) or with
other diseases such as pneumonia (Kenya and Mali). Some women claimed that malaria symp-
toms could be confused with pregnancy so that sometimes treatment was sought very late, after
the infection was well established.
These factors combined suggest an importance placed by women in both countries on sus-
pected cases requiring diagnoses at a health centre or hospital, before seeking treatment. In
Mali, severity of the illness was also a consideration for going to a health centre, for example
when pregnant women or infants had severe malaria, known locally as ‘kono’ (used also to
mean severe or cerebral malaria).
Perceptions of treatment drugs. Women and men in both countries had many precon-
ceptions about the different antimalarials or herbal medicines available for the treatment of
malaria, mostly on their safety or efficacy for use in pregnancy. Women and men in Kenya cor-
rectly observed that ‘Fansidar’ (SP) was no longer effective for treatment of malaria, and the
men explained that some chemicals had been added or that the doses were incorrect. The
newer drugs were widely perceived to be more effective than the older drugs in both countries.
Kenyan women were concerned about using drugs correctly (as prescribed) and about safety,
and Coartem (AL) and quinine were said to be too powerful to be used in for treatment in preg-
nancy. Drugs obtained from chemists were said to potentially harm the baby and the prefer-
ence was to obtain treatment from a trained provider at a health facility following
diagnostic confirmation.
In Mali, both herbal remedies and bio-medicines were reportedly used to treat malaria in
pregnancy, and herbal remedies used if women could not afford bio-medicines. Bio-medicines
were seen to be more effective than herbal remedies, with a more rapid mode of action, but
there was some confusion over the application of some drugs such as ACTs, which were
thought to be used for both treatment and prevention. In Mali, the misuse of traditional plants
for treatment was seen to cause problems, and if someone had received only bio-medicines
from birth, traditional herbal remedies were said to be no longer be effective in adulthood; we
labelled this sub-theme the ‘habit’ of bio-medicines.
Experience of treatment drugs. Women in both countries complained of side effects
from some of the antimalarials they had used; quinine was said to cause deafness and scratch-
ing or itchiness (Kenya) or buzzing in the ears and dizziness (Mali). One woman in Mali ob-
served that she could avoid adverse events if she ate enough before taking quinine. There were
mixed views among women in both countries as to the effectiveness of quinine, being either
very effective at fighting malaria or to no longer work at any dose of quinine injection (300 mg,
400 mg, 600 mg, and 800 mg)(Mali). Similarly, SP was said to cause nausea and to no longer
work for treatment in Mali.
Pregnancy disclosure to prescribers. Disclosing one’s pregnancy to the person prescrib-
ing treatment was recognised as important by most women in Kenya and Mali, to avoid being
given harmful drugs that may cause miscarriage and because, as early pregnancy was not visi-
ble, providers would not always think to ask a woman whether or not she is pregnant. However
not all women were willing to disclose their pregnancy status, as described above in response to
questions about ANC access.
Cost (affecting source and type of treatment). Affordability was the main reason for
women not to seek treatment at a formal health facility or to choose one type of medication
over another, especially in Mali where people without money resorted to herbal medicines.
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Drugs on the whole were considered too expensive, and men in Mali complained that the pub-
licity about ACTs was confusing; although the ACTs prescribed to pregnant women were free,
the partner drugs were not free. Doctors and community health workers (known as relais)
were said to take advantage of this situation by selling the partners drugs themselves.
Perceptions of different providers and other factors affecting source of treatment. The
factors affecting women’s choice of treatment source represent a complex inter-play of several
factors, including drug availability, competence of health staff, convenience and fear of a partic-
ular provider. In Kenya, although formal health services were the preferred choice due to com-
petence of the providers, drug stock-outs meant that women often ended up buying the drugs
from pharmacies, and surmised that they may as well have gone directly to the pharmacy. Con-
venience was also an important consideration, resulting in local shops and chemists being used
as a first port of call, resorting to a health facility only if the condition did not improve. In Mali,
the situation was very different; women who could afford to showed a preference for going to a
health centre to get tested for a diagnosis and to be prescribed bio-medicines. The decision of
where they go was also influenced by the type of reception they thought they would receive at
the health centre.
Access and use of IPTp
Factors affecting pregnant women’s access and use of IPTp based on the data were categorised
into five main themes: effectiveness; application(s); dose regimen; safety; and side effects
(Table 4).
Effectiveness and Application(s). The views of women in Mali of the effectiveness of
IPTp-SP were inconsistent, with women stating that IPTp-SP had been both effective and
ineffective at preventing malaria. Although women in Kenya and Mali correctly identified
SP for prevention, several women in Mali claimed that SP was still being used to treat
malaria.
Dose regimen, Safety and Side effects. Although not explicitly requested, an adolescent
woman aged 18 years in Banankoro village in Mali was able to state the correct administration
of IPTp-SP (3 tablets taken together and a second dose half way through her pregnancy), and
that she took no other drugs for a week after taking it. Women at the CSRef were asked to ‘eat a
lot’ before they took IPTp, suggesting they were not given it by DOT. Women in Mali had con-
flicting experiences of side effects (malaise and dizziness) or no side effects, and linked the
vomiting associated with taking SP with taking the drug when hungry. A Kenyan woman
claimed that SP gave her body rashes and a severe headache. Several women from both villages
in Kenya thought that SP was too powerful for use in pregnancy, and that it could harm the
baby or cause miscarriage.
Access and use of ITNs
Factors affecting pregnant women’s access and use of ITNs were categorised into five main
themes: sources of nets; stock outs; unofficial practices among health providers; effectiveness;
and seasonal use or other factors affecting use (Table 5).
Sources of nets, the sale of free nets/favouritism and stock-outs. Women in Kenya and
Mali obtained their ITNs from a variety of sources though predominantly from ANC or hospi-
tal, child health clinics and EPI, mainly (though not always) provided free-of-charge. Other
sources of nets in Kenya were campaigns or shops, and in Mali, the pharmacy or from their pa-
rents (adolescents). Although most women said ITNs were given to them free at ANC, one
woman in Kenya complained she was charged. In Mali, several women complained that they
did not always receive their free ITN, and that doctors gave the ITNs to other women who had
Access to Prevention and Treatment of Malaria in Pregnancy
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not attended ANC, or simply that the ITNs were not meant for them. There were conflicting
reports of when they were given the ITN at ANC, with women in the same village in Mali
claiming different circumstances; one woman claimed women should get an ITN after ‘a num-
ber of’ ANC visits, and another that you got a net at your first ANC visit, and another when
your child got their immunizations at 9 months. Women in both Kenya and Mali reported
stock-outs of nets at ANC, hospital and EPI clinics.
Effectiveness, Seasonal use or other factors affecting use. ITNs were understood to have
an ‘effect’ which waned when the nets got too dirty so women and men reported that they ‘re-
freshed’ the insecticide with Powertab (Kenya) or ‘re-impregnated’ it with Bloc (Mali).
Although women claimed they almost always used their ITNs, men in Kenya stated that
their wives did not always use them, especially when there were no mosquitoes. In Mali,
women reported that they had to sleep under a mosquito net or else they wouldn’t be able to
sleep due to mosquito nuisance, however another woman alluded to seasonal use. Use among
Table 4. Factors affecting pregnant women’s practices for the prevention of malaria: IPTp.
Themes KENYA: Sub-themes & Quotations from study participants MALI: Sub-themes & Quotations from study participants
Effectiveness Fansidar was for malaria but malaria of this time it cannot treat.
(R10: single woman aged 20 years, 1 previous pregnancy,
Kakola)
No, it [SP] is given free. But it gives a little malaise, dizziness.
At delivery I got ‘le palu’ [malaria]. (P1 : woman aged 26 years,
ﬁrst pregnancy, Banankoro)
It gave good health as well as my baby. I did not get sick and
my baby also from the beginning to the end of the pregnancy I
never get sick, I never get vomit. (P5: adolescent aged 18, no
previous pregnancies, Banankoro)
Safety It is not good because it is powerful and it can make you
miscarry. (R7 married woman aged 32 years, multiparous,
Koru)
It [Fansidar] is not okay because it can affect the baby.(R3,
married woman aged 20 years, no previous pregnancies,
Kakola)
Side effects and
eating
I used it but it almost turned me mad; I was feeling body
rashes and the headache also advanced and was serious. (R4:
married woman aged 20, multiparous, Kakola)
I got it also, and I got recovered. I got it in the health centre. I
used the treatment without any adverse event. (P6 : woman
aged 23 years, multiparous, Sagni)
It [SP] made me sick before I get recovery because I took it
when I was hungry and I get dizziness. (F8: adolescent aged
15, no previous pregnancies, Banankoro)
I got it [SP] at the CSREF, they ask to eat a lot before you take
it. I took mine at home. It gave me dizziness. (P2: woman aged
21 years, ﬁrst pregnancy, Banankoro)
Use for treatment
and/or prevention
When I went to the clinic I was given fansidar to help me
prevent malaria and I did not pay any cash. (R8: married,
adolescent aged 17 years, multiparous, Koru).
Before, we used chloroquine, our parents used it for
prevention. My father was physician, he used chloroquine for
prevention. He used to give us chloroquine regularly. But with
new drug, we are obliged to take them. I take fansidar for
prevention. (P1 : woman aged 48 years, 1 previous
pregnancy, Banankoro)
It helps prevent malaria and I was told to go and buy in the
chemist. (R4: married, adolescent aged 17 years, multiparous,
Koru)
It [SP] is also used to treat ‘le paludisme’ [malaria]. I got it
during the CPN [ANC]. (P4 : woman aged 36 years, 7 previous
pregnancies, Sagni)
Number of tablets
and doses
When you take it, it is not allowed to take another medicine for
a week. I took it at home. (P5 : woman aged 37 years, 6
previous pregnancies, Banankoro)
Yes, I even have the habit of that. They say that 3 tablets have
to be taken together. The week that I used it, I did not use any
other drug. I took the second dose while I am half of my
pregnancy. In total I took two doses. (P5: adolescent aged 18,
no previous pregnancies, Banankoro)
doi:10.1371/journal.pone.0119848.t004
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adolescents appeared to be less of a habit; an adolescent aged 17 years with no previous preg-
nancies in Banankoro village claimed that she was too lazy to attach the net and if her sister
didn’t hang it, she would not use it.
Table 5. Factors affecting pregnant women’s practices for the prevention of malaria: ITNs.
Themes KENYA: Sub-themes & Quotations from study
participants
MALI: Sub-themes & Quotations from study participants
Effectiveness I always use net and wash it after the level of power tab has
gone down. (R5: married man aged 33 years, Koru)
To protect against malaria. Me and my children sleep under
a net. If it becomes dirty, I impregnate it using an insecticide
called ‘Bloc'. (P8, woman aged 42 years, multiparous,
Sagni)
Stock outs I went to the hospital and I found that the nets were over.
(R6: married woman aged 30 years, multiparous, Koru)
They said that it is ﬁnished, while in fact after one ANC and
EPI, they must provide you an impregnated bed net. But any
time if you go, it is ﬁnished. (P4: woman aged 30 years,
multiparous, Banankoro)
Free or not; from ANC or
other
I bought the ﬁrst net but when the campaign for malaria
came I was given some from the people from that
campaign. (R6: married man aged 66 years, Kakola)
If you spend more time before you get pregnant, you use
insecticide used for your moustiquaire imprégnée d
‘insecticide. You can also get it during the vaccination
(immunization) of children less than 5. Here in our health
centre we don’t buy it. (P3; woman aged 42 years,
multiparous, Sagni)
I took the baby to the clinic and I was given net free. (R7:
married adolescent aged 18 years, 3 previous pregnancies,
2 children, Koru)
During EPI vaccination at the health centre, I got it and I use
it during the night to be protected against mosquitoes and
small insects. Since I start to use it I sleep very well. (P1:
adolescent aged 16, no previous pregnancies, Sagni)
I have one which I was given free when I went to the clinic
while pregnant. (R1: married adolescent aged 18 years,
multiparous, Koru)
I got mine during the EPI vaccination of my brother and they
prescribe him also drugs. (P4: adolescent aged 16, no
previous pregnancies, Sagni)
I went to the hospital and I was given free of charge. (R4:
married, adolescent aged 17 years, multiparous, Koru)
You do a number of visits to ANC and they provide to you.
(P10 : woman aged 28 years, multiparous, Sagni)
For the ﬁrst time at the ANC, and when the child got 9
months if you come for EPI they provide you mosquito net.
(P5, woman aged 41 years, multiparous, Sagni)
Seasonal use or other
factors affecting use
Even though my wife use net but not always because you
might think that the children are under net but not and
when it’s rainy season, there might be some stagnant water
where mosquitoes breed. (R2: married man aged 50 years,
Koru)
Sometimes I am lazy to attach my bednet. If my sister
doesn’t attach it, I just sleep like that. (P2: adolescent aged
17, no previous pregnancies, Banankoro)
I can’t lie that we always use net because a times there are
no mosquitoes but if it is rainy season, we use nets
especially for the young one to prevent mosquitoes. (R1:
married man aged 44 years, Koru)
If we don’t sleep under bednet, then we won’t be able to
sleep [too many mosquitoes]. (P10 : woman aged 28 years,
multiparous, Sagni)
In this period [rainy season] all people sleep under a bednet.
(P7: woman aged 30 years, multiparous, Sagni)
Favouritism and providers
selling free nets to clients
Sometimes you may go to the hospital that today I must
ask the nurse for a net and you may ﬁnd the nurse hungry
that she informs you that nets we are selling! (R4: married
woman aged 20, multiparous, Kakola)
I have faith in one doctor from [name health centre] because
I did all my ANC, but when bednet arrived she said that it is
not for us, but for others. We were 6 people in that situation.
We use taxi and other means of transport to come to the
health centre and they refuse to provide us bednet. The
doctors sell impregnated bed net. (P3 : woman aged 26
years, multiparous, Banankoro)
It is segregation, favouritism, and all kind of things. For
example, if they received 40 bednets, the doctors give to
5–6 people who did not visit the health centre. If we get
there, they said that it is ﬁnished. (P4 : woman aged 30
years, multiparous, Banankoro)
doi:10.1371/journal.pone.0119848.t005
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Household decision making on health seeking
Women in both countries stated that husbands played an important role in decisions over care
seeking among pregnant women, although the majority of women admitted that if their hus-
bands were not available, amenable or able to pay for health care, they would go regardless.
Women generally asked their husband, as chief of the family, permission before they sought
health care, mainly because the husband was also expected to pay for this care. In Mali, hus-
bands were said to force their wives to take any medication prescribed by doctors, including an-
timalarials, and parents or in-laws also provided encouragement or advice on health seeking.
Other important influencing agents were elders (Kenya) or village chiefs (Mali), midwives
and doctors, and relais (Mali) or older members of the community or neighbours (Kenya). In
Kenya, some churches were said to forbid believers from going to hospital. Radio and TV were
also said to influence health care seeking for ITNs and drugs in Kenya and Mali, respectively.
Discussion
The FGDs with different groups of women of childbearing age and men in Kenya and Mali
provides useful information that can be used by the malaria and reproductive health pro-
grammes in both countries to inform strategies to improve the delivery and uptake of IPTp,
ITNs and case management of malaria in pregnancy. The qualitative data supports many of
the quantitative findings from both the household surveys [17,18] and health facility surveys
[15,16] that were undertaken in parallel to this study with regard to ANC access and coverage
of IPTp and ITNs.
Women recognised the benefits of ANC and were eager to attend ANC despite some nega-
tive perceptions and inconvenience so as to ensure a safe pregnancy and to avoid complications
at delivery, or to facilitate admission without problems in case complications at delivery, a find-
ing consistent with another study conducted in Kenya, Ghana and Malawi [24] and is consis-
tent with high rates of ANC use in another study in a semi-urban area of Mali [25]. Particular
mention was made of wanting to have their pregnancy monitored and getting the position of
the baby checked. The professional advice and testing services of professional health staff were
valued and actively sought, in preference to shop bought medicines and herbal remedies; this
trust in health providers has been observed elsewhere [26]. These factors serve to promote
women’s demand for ANC services; however poor quality services and poor attitudes amongst
health staff undermine this demand and deter women from using ANC services more frequent-
ly. This was illustrated in the household surveys in Kenya and Mali; although 87% and 81% of
women made at least one ANC visit respectively, only 33% and 42% made 4 or more visits re-
spectively [17,18], the drop in ANC attendance was particularly marked in Kenya.
Poor health provider practices were a concern in both countries, and specifically poor be-
haviour among health providers in Kenya and poor quality services and reception in Mali.
These issues are not new, and add to the body of evidence calling for improvements in the qual-
ity of antenatal care in general [24,27]. The cost of accessing antenatal care was perceived as
the biggest barrier to accessing ANC in both Kenya and Mali, as described in a review of access
to ANC [27]. Although many women make at least one ANC visit, the cumulative costs of re-
peat ANC visits over the course of a pregnancy, together with poor quality services, reduce the
likelihood of women making repeat visits. Kenya policy historically has been to provide free
ANC services (palpation, family planning, HIV testing, IPTp, ITNs and tetanus toxoid), al-
though tests for the ANC profile (urinalysis, Hb, syphilis and blood grouping) are routinely
charged. In Mali, charges are levied for most services apart from ITNs.
Individual barriers to ANC access, such as fear of blood testing for HIV, injections or taking
certain drugs in pregnancy, were mentioned by adolescents in particular, and were
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predominantly reported in Kenya. The impact of fear of blood testing for HIV on ANC atten-
dance has been reported elsewhere [28] and the institutionalisation of PMTCT at ANC in
Kenya may act as a deterrent for adolescents attending ANC. Another barrier to attending
ANC among adolescents was pregnancy disclosure among unmarried adolescents. These fac-
tors support similar studies which have identified adolescents as a particularly vulnerable
group [24,29], and points to the need for adolescent-friendly services which specifically target
and encourage younger women to attend ANC by addressing the issues described above and
ensuring confidentiality.
Women in both countries described malaria in pregnancy as dangerous and recognised the
risks to themselves and their infants, a finding that is consistent with studies in other countries
in East and Southern Africa and The Gambia [30,31]. Pregnant women were seen to suffer
from malaria more than others since they were already burdened with carrying a baby, and
that malaria in pregnancy harms not one but two people, mother and baby. In Kenya, HIV in-
fection was also seen to predispose people to malaria due to HIV being another blood infection,
causing a weakened state. Pregnancy symptoms were said to be similar to malaria symptoms,
and significant value was placed on getting a laboratory test to confirm suspected malaria be-
fore seeking treatment. In Mali, diagnosis was reported to be as important as treatment of ma-
laria, and if women could not afford both, they would get the diagnostic test and resort to
herbal remedies which were cheaper. The anti-plasmodial activity of local plants and herbs is
poorly understood within the scientific community [32]. The importance pregnant women in
Kenya placed on testing for malaria has not always been the case [30] but was reported in an-
other more recent study [33], and may be a new phenomenon linked to increased awareness of
the value of testing and treatment for HIV.
The source of treatment for malaria sought by women was driven by a complex interplay of
several factors including severity of the illness, perceived drug safety, drug efficacy and avail-
ability, trust in particular providers, convenience and cost, consistent with another study in
Kenya [34]. The risks associated with malaria in pregnancy and severe malaria meant women’s
preference was to seek diagnosis and drugs from a trained provider at a health centre or hospi-
tal. Convenience and cost mitigated their ability to always pursue their preferred choice, using
shops in Kenya, or herbal medicines in Mali, both of which were convenient, cheap and
sourced locally, and high rates of self-treatment in Mali has been observed in a previous study
[35]. Stock-outs of antimalarials at health facilities also resulted in women using alternative
sources. These alternative sources were not trusted to provide drugs that were safe and they did
not provide a differential diagnosis. Although antimalarials were provided free to pregnant
women by the Malian government, having to pay for the partner drugs calls for the govern-
ment to review and clarify the messages aired on Mali television. Women’s confusion about
which drugs were safe to take in pregnancy, and complaints of unpleasant side effects from cer-
tain drugs, or that efficacious drugs such as AL were ‘too strong’, which affects compliance
[24], suggests that women are not provided with sufficient information about these and other
drugs given at ANC. The report fromMalian women that eating before taking certain drugs in
pregnancy reduced the risk of side effects confirms findings from our health facility survey
[16]. There needs to be community education about medications that are safe and unsafe in
pregnancy, with a focus on the safe drugs (e.g. SP, AL in second and third trimester, quinine),
to remove the notion that some drugs that are effective are too strong to be safe.
Concerning IPTp, women participants in both Kenya and Mali reported having experienced
side effects to SP and some voiced concern that SP was no longer effective for treatment of ma-
laria, supporting our findings from household surveys conducted in parallel to this study in
Kenya and Mali [17,18]. Although SP is no longer efficacious in these countries for the treat-
ment of malaria, it remains an effective means to prevent malaria through IPTp. Women
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however did not distinguish between efficacy of SP for prevention and treatment. Our house-
hold surveys showed uptake of two doses of IPTp in Kenya and Mali was low, and the propor-
tion of women who received IPTp by DOT was very low, particularly in Mali. This is
consistent with the report in Mali that the CSRef told women to eat before taking IPTp-SP, and
with our health facility survey where health providers gave this as a reason for not adhering to
DOT [16]. Knowledge of malaria and its prevention was a predictor of IPTp receipt and, to-
gether with not experiencing any side effects to the previous dose, receipt by DOT in Kenya
[18]. Predictors of receiving IPTp by DOT in Mali were being unmarried and living more than
5km from the health facility [17]. Women and men in the FGDs in Mali said that husbands
played an important role in determining health seeking practices of pregnant women and paid
the costs for women to attend ANC. Previous studies have stated that women need their hus-
bands’ approval before taking drugs in pregnancy [36,37]. Women who live close to a health fa-
cility may argue that they need to return home to eat before taking their IPTp dose.
Programmes need to ensure that women and household members are provided with accurate
information to help them understand the importance of each of the national recommenda-
tions: for IPTp, early diagnosis and treatment with safe and efficacious drugs, and ITN use.
ITN use among pregnant women was high in both countries (80% and 93% in Kenya and
Mali, respectively) and a high proportion of nets used by pregnant women were said to be ob-
tained from ANC (74% in both countries) [17,18]. As many women in Mali first attend ANC
in their 1st trimester (41%), if ITNs are provided at first ANC visit, there is an opportunity for
women to receive protection from an ITN use from early pregnancy. The end of the first tri-
mester is a key period during which 65% (95% CrI, 61%–70%) of the potentially infected preg-
nancies first experience infection, and primigravidae experience a high proportion 39% (95%
CrI, 33%–46%) of the total potential malaria-attributable LBW burden [38], hence additional
strategies are needed which target women before or early in pregnancy and adolescents.
Women in Kenya make their first ANC visit later than in Mali (median of 5 months gestation
[IQR 4–6] compared to 4 months gestation[IQR 3–5]) highlighting the need for greater efforts
in both countries, and Kenya in particular, to encourage earlier attendance at ANC. The find-
ing that ANC was identified as an important source of nets in both the qualitative and quanti-
tative studies in both countries supports the continued delivery of ITNs to pregnant women
through ANC. The report by women in Mali that health providers show favouritism in distrib-
uting ITNs may be linked to whether they live in the health facility’s catchment areas, as ob-
served in our health facility survey [16], or may be a legitimate cause for concern.
The FGD findings have several implications for the health service delivery in Kenya and
Mali (Table 6).
Governance: Reports of staff charging unofficial fees for services that should have been pro-
vided free, or prioritised clients who were able to pay bribes, calls for systems for ensuring ac-
countability of staff, such as an anonymous complaints system, such as a hotline for clients to
report unofficial fees for ACTs as used successfully in Kenya, and advertising government fee
policies in national newspapers. To promote respect for ANC clients, the health system would
benefit from exploring opportunities for a patient-centred approach to service delivery, and en-
suring that the teachers and mentors of medical staff are trained to provide compassionate care
during assisted deliveries. Performance-based remuneration which ties their salaries and bo-
nuses to outcome measures should include measures of patient satisfaction and revenue.
Human resources: Trainee staff need to be supervised by fully qualified personnel. Ministries
of health need to ensure adequate deployment of staff to counteract long waiting times, and
district managers should support facility managers to review staff rosters to make sure suffi-
cient qualified staff are on duty during busy ANC clinics.
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Service delivery: Formal channels for complaints from ANC attendees are needed to report
abuse of non-fee paying systems together with performance-based schemes which utilise cover-
age data for key services, such as proportion of women on their 1st antenatal visit who received
an ITN. Peers should be encouraged to report such practices, though that might prove more
difficult to enforce.
All health providers in the public, private and commercial sectors as well as pregnant
women need information on the correct administration of antimalarial drugs to treat malaria
in pregnant women, and prescribers of drugs need to be trained to ask all women of childbear-
ing age whether they suspect they may be pregnant, or to offer a pregnancy test.
Similarly all public and private sector providers should be reminded that HIV testing and
counselling should be voluntary.
Products and technologies: Information on the safety, efficacy and side effects of drugs used
in pregnancy should be provided to pregnant women as part of routine health education at
ANC and through media channels that reach all community members. Similarly information
on the benefits of ITN use throughout pregnancy, and of IPTp, should be provided.
Stock outs of ITNs were reported in both countries, supporting data from the health facility
studies in Mali [15,16]. Although it is not known whether this was a district or nationwide
shortage, a continuous supply of ITNs requires adequate budgeting, procurement and distribu-
tion of ITNs and a system that ensures ITNs destined for ANC do not get diverted to
Table 6. Implications of ﬁndings for programmes.
Health system
building block
FGD Themes Implications for programmes
Governance Corruption among staff Introduce systems that promote staff accountability
Lack of respect to patients Provide staff with patient-centred training; guidelines and training for assisted deliveries to
include provider-client centred approach; performance-based remuneration; provide an
anonymous complaints system for clients
Human resources Staff not fully qualiﬁed or poorly
trained
Deploy only fully qualiﬁed staff or ensure that trainees are accompanied or supervised by
fully qualiﬁed personnel.
Staff overburdened; long waiting
times
Ensure adequate human resources; improve rosters for staff to ensure enough staff are
available at busy ANC times
Service delivery Staff applying informal fees for
ITNs or antimalarials
Introduce systems that promote staff accountability (see also Governance)
Administration of drugs in
pregnancy
Ensure all providers (pharmacists, private sector clinics and public sector facilities) are
trained to ask women of child bearing age their pregnancy status to avoid exposure to
ACTs in ﬁrst trimester
HIV testing Ensure that HIV testing involved adequate consenting without undue pressure
Products and
technologies
Side reactions to drugs Information for women and households about how to take drugs and which side effects to
anticipate
Information on safety and efﬁcacy
of drugs
Information for women and households on the safety and efﬁcacy of drugs
Seasonal use of ITNs Information of risks associated with not using an ITN in all seasons, especially in
pregnancy
Stock out of ITNs Ensure continued supply through improved budgeting, procurement and distribution; avoid
diverting nets to population-wide campaigns
Information systems Performance of health staff Use data on proportion of ANC attendees who get certain services to assess performance
for performance-based remuneration
Financing Fees for ANC services Review of fee structures for ANC (Mali)
Antimalarial partner drugs are
expensive
Governments and partners to review fees for non-antimalarial partner drugs to treat
pregnant women and the necessity of prescribing partner drugs
doi:10.1371/journal.pone.0119848.t006
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population-based campaigns. Systems to ensure continuous supplies of antimalarials are also
needed, to avoid preventing women from accessing treatment from qualified providers.
Financing: The biggest barrier to attending in ANC in both countries was cost; this calls for
an urgent review of ANC fee paying structures, and preferably removal of all ANC fees.
Strengths and limitations
The study draws findings from two countries with very different health system and social con-
texts to increase the range of perceptions, behaviours and contexts identified, to allow compari-
son between sites, to explain the quantitative data from our household surveys and to compare
these with the findings of our health facility surveys. The research team aimed to encourage
openness among participants by holding separate FGDs for women, men, and adolescents, and
by using female moderators for the FGDs with women, and male moderators for the FGDs
with men. FGD are a technique to understand the normative discourse in a community and
the views of people who do not have direct close experience of ANC may differ significantly
from real experiences and practices. It is possible that the research teams from KEMRI and
MRTC were known to the participants for conducting clinical trials, resulting in a social desir-
ability bias. While FGDs were held in two communities, results should not be considered gen-
eralisable to other communities unless they have similar contexts. The broad scope of the
guide, which included ANC as well as malaria specific practices, has limited more in-depth dis-
cussions on each of the topics such that the emergent themes may not have reached saturation.
Conclusion
Despite the availability of relatively simple interventions to prevent the adverse consequences
of malaria in pregnancy that can be delivered through the ANC platform, access and use is far
from optimal. In Kenya and Mali, pregnant women experience substantial barriers to receiving
quality care for malaria treatment and prevention, many of which have been found in other set-
tings in Africa. Remedial action needs to be taken jointly by malaria and reproductive health
programmes in these countries if coverage of malaria and other ANC interventions is to im-
prove, both the supply and demand for quality services across the antenatal care platform. Ac-
cess to quality antenatal services is a rights-based issue, and more needs to be done to increase
the health service accountability to pregnant women.
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